VCM
AST.WS

Versant Capital Management’s Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) AST.WS Stock Holding History

Versant Capital Management’s Portfolio AST.WS Stock Details AST.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-10
Closed – – 1738
2017
Q3 		$0 Hold
10
– – ﹤0.01% 1673
2017
Q2 		$0 Hold
10
– – ﹤0.01% 1635
2017
Q1 		$0 Hold
10
– – ﹤0.01% 1630
2016
Q4 		$0 Hold
10
– – ﹤0.01% 1639
2016
Q3 		$0 Hold
10
– – ﹤0.01% 1585
2016
Q2 		$0 Buy
+10
New +$5 ﹤0.01% 1533

Versant Capital Management's AST.WS Position: Q4 2017 in Review

Versant Capital Management sold out of Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) (AST.WS) in Q4 2017, closing a stake of 10 shares.

Versant Capital Management first reported a position in AST.WS in Q2 2016 and held it in 6 quarters. The position peaked at $0 in Q3 2017. 0 funds tracked by Wall St. Rank hold AST.WS as of Q4 2017.

  • Versant Capital Management reported no remaining Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position as of Q4 2017 after selling out during the quarter.
  • Versant Capital Management sold 10 Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) shares in Q4 2017.
  • Versant Capital Management first reported a position in Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) in Q2 2016 and held it in 6 quarters.
  • Versant Capital Management's Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position peaked at $0 in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) as of Q4 2017.

Based on Versant Capital Management's 13F filing for Q4 2017, filed 19 Apr 2018.